D'Cruz Osmond J, Uckun Fatih M
Drug Discovery Program, Department of Virology, Parker Hughes Institute, 2657 Patton Road, St. Paul, MN 55113, USA.
Fertil Steril. 2004 Mar;81 Suppl 1:831-41. doi: 10.1016/j.fertnstert.2003.08.037.
Stampidine (2,'3'-didehydro-3'-deoxythymidine-5'-(p-bromophenyl methoxy alaninyl phosphate) is a novel aryl phosphate derivative of stavudine/d4T with broad-spectrum anti-HIV activity in vitro and in vivo. This study investigated the potential utility of stampidine as a nonspermicidal microbicide.
Prospective, controlled study.
Center for Advanced Preclinical Sciences and Reproductive Biology Department.
PATIENT(S): Seven sperm donors.
ANIMAL(S): Fifty-two sexually mature, female and twenty-four male New Zealand white rabbits.
INTERVENTION(S): Human semen and genital tract epithelial cells were exposed to stampidine (up to 1 mM). Ovulated does in subgroups of 12 were artificially inseminated with rabbit semen pretreated with stampidine (1 mM) or vehicle. Does in subgroups of four and three, respectively, were exposed intravaginally to a gel or a thermoreversible ovule formulation with and without 0.5%, 1.0%, or 2.0% stampidine (9 to 36 mM) for 14 days.
MAIN OUTCOME MEASURE(S): Effect of stampidine on human sperm motility, kinematics, penetration through cervical mucus, and epithelial cell viability. Reproductive parameters on gestation day 8. Vaginal tissues were histologically scored 24 hours after dosing.
RESULT(S): Exposure of human sperm to stampidine even at a concentration 10(6)-times higher than its in vitro anti-HIV-1 activity (50% inhibitory concentration = 1 nM) had no adverse effect on sperm motility, kinematics, cervical mucus penetrability, or the viability of vaginal and endocervical epithelial cells. Reproductive indices of pregnancy rate, embryo implantation, and preimplantation losses were not affected by pretreatment of rabbit semen with stampidine. Gel formulations of 0.5% to 2.0% stampidine (9 to 36 mM) lacked mucosal toxicity.
CONCLUSION(S): The broad-spectrum anti-HIV agent stampidine had no adverse effect on sperm functions, was not cytotoxic, and did not induce mucosal toxicity. Stampidine has clinical potential as a prophylactic microbicide without contraceptive activity.
司他帕定(2,'3'-二脱氢-3'-脱氧胸苷-5'-(对溴苯基甲氧基丙氨酰磷酸酯))是一种新型的司他夫定/d4T芳基磷酸酯衍生物,在体外和体内均具有广谱抗HIV活性。本研究调查了司他帕定作为一种非杀精剂的潜在用途。
前瞻性对照研究。
高级临床前科学与生殖生物学系中心。
7名精子捐献者。
52只性成熟的雌性和24只雄性新西兰白兔。
将人类精液和生殖道上皮细胞暴露于司他帕定(浓度高达1 mM)。将12只一组的排卵母兔用经司他帕定(1 mM)或赋形剂预处理的兔精液进行人工授精。分别将4只一组和3只一组的母兔经阴道暴露于含或不含0.5%、1.0%或2.0%司他帕定(9至36 mM)的凝胶或热可逆栓剂制剂中14天。
司他帕定对人类精子活力、运动学、穿透宫颈黏液的能力以及上皮细胞活力的影响。妊娠第8天的生殖参数。给药24小时后对阴道组织进行组织学评分。
即使将人类精子暴露于浓度比其体外抗HIV-1活性(50%抑制浓度 = 1 nM)高10^6倍的司他帕定中,也不会对精子活力、运动学、宫颈黏液穿透性或阴道和宫颈内膜上皮细胞的活力产生不利影响。用司他帕定预处理兔精液不会影响妊娠率、胚胎着床和着床前损失等生殖指标。含0.5%至2.0%司他帕定(9至36 mM)的凝胶制剂无黏膜毒性。
广谱抗HIV药物司他帕定对精子功能无不利影响,无细胞毒性,也不诱导黏膜毒性。司他帕定作为一种无避孕活性的预防性杀菌剂具有临床应用潜力。